재택 주입 요법 시장 기회, 성장 촉진요인, 업계 동향 분석 및 예측(2025-2034년)

The Global Home Infusion Therapy Market was valued at USD 36.6 billion in 2024 and is estimated to grow at a CAGR of 9.2% to reach USD 89.8 billion by 2034.

Market expansion is driven by the rising prevalence of chronic diseases, the shift toward cost-effective healthcare solutions, advancements in infusion technologies, and the growing elderly population. Home infusion therapy involves delivering drugs or nutrients directly into a patient's bloodstream via intravenous (IV) or subcutaneous methods in a home setting. This therapy is commonly applied for antibiotics, chemotherapy, pain management, and parenteral nutrition over prolonged periods. The increasing incidence of chronic conditions such as cancer, diabetes, gastrointestinal disorders, immune deficiencies, and heart failure is a major factor boosting demand. Home infusion therapy allows patients to receive continuous and safe treatment outside hospital facilities, reducing pressure on healthcare systems while enhancing convenience and comfort. The introduction of portable infusion pumps, smart devices, and remote monitoring systems further ensures safety, precise dosing, and real-time communication between patients and healthcare providers, driving broader adoption.

The infusion pumps segment accounted for 52.7% share in 2024 owing to their essential role in chronic disease management and home care. These devices provide programmable and accurate dosing for therapies such as pain management, hormone treatments, and cardiac medications, reducing the risk of under- or over-infusion. Their precision and reliability make them critical for ensuring safe therapy in home settings.

The direct sales captured a share of 71.1% in 2024 and are expected to reach USD 62.7 billion through 2034. This approach allows manufacturers to offer competitive pricing by eliminating intermediary margins. Bulk purchase incentives and long-term agreements attract healthcare providers seeking cost efficiency, boosting the adoption of infusion pumps, IV kits, and associated disposables.

North America Home Infusion Therapy Market held a 44.2% share in 2024. The region's high prevalence of chronic illnesses such as cancer, diabetes, Crohn's disease, and immune deficiencies has driven strong demand for long-term IV therapies. The growing patient population in the U.S. and Canada is supporting steady growth in home infusion therapy services.

Prominent players in the Global Home Infusion Therapy Market include ICU Medical, Terumo, Fresenius Kabi, Moog, Mindray, B. Braun, Baxter, Nipro, JMS, Avanos (Halyard Health), Contec Medical Systems, Polymed, Erenler Medikal, AMSINO, and Becton Dickinson and Company. Companies in the Home Infusion Therapy Market employ several strategies to strengthen their presence and market position. They focus on continuous innovation, developing portable and user-friendly infusion pumps with advanced safety and remote monitoring features. Strategic partnerships with hospitals, clinics, and home healthcare providers expand distribution networks and enhance credibility. Geographic expansion into emerging markets allows access to new patient populations, while mergers and acquisitions help consolidate technology and product portfolios.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Product trends
  • 2.2.3 Application trends
  • 2.2.4 Distribution channel trends
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Growing hospital acquired infections
    • 3.2.1.2 Rising prevalence of chronic diseases
    • 3.2.1.3 Advancements in technology
    • 3.2.1.4 Growing geriatric population
    • 3.2.1.5 Increasing preference towards at-home healthcare solutions
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Dearth of reimbursement
    • 3.2.2.2 Safety concerns and risk of failure associated with home infusion devices
  • 3.2.3 Market opportunities
    • 3.2.3.1 Increasing adoption of intravenous immunoglobulin (IVIG) therapy
    • 3.2.3.2 Growing demand for personalized care
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
• 3.5 Technology landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Reimbursement scenario
• 3.7 Trends in home infusion therapy industry
• 3.8 Pricing analysis, 2024
• 3.9 Future prospects for home infusion therapy industry
• 3.10 Porter's analysis
• 3.11 PESTEL analysis
• 3.12 Gap analysis
• 3.13 Start-up scenario
• 3.14 Consumer behaviour analysis
• 3.15 Value chain analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
  • 4.3.1 Global
  • 4.3.2 North America
  • 4.3.3 Europe
  • 4.3.4 Asia Pacific
  • 4.3.5 LAMEA
• 4.4 Competitive positioning matrix
• 4.5 Competitive analysis of major market players
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Infusion pumps
  • 5.2.1 Syringe
  • 5.2.2 Volumetric
  • 5.2.3 Ambulatory
  • 5.2.4 Insulin
  • 5.2.5 Other infusion pumps
• 5.3 Needleless connectors
• 5.4 Intravenous sets
• 5.5 IV cannulas

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Anti-infective
• 6.3 Enteral nutrition
• 6.4 Specialty pharmaceuticals
• 6.5 Parenteral nutrition
• 6.6 Hydration therapy
• 6.7 Chemotherapy
• 6.8 Other applications

Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Direct sales
• 7.3 Indirect sales

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 AMSINO
• 9.2 B. BRAUN
• 9.3 Baxter
• 9.4 Becton Dickinson and Company
• 9.5 Contec Medical Systems
• 9.6 ERENLER MEDIKAL
• 9.7 FRESENIUS KABI
• 9.8 Halyard Health (AVANOS)
• 9.9 ICU Medical
• 9.10 JMS
• 9.11 Mindray
• 9.12 Moog
• 9.13 NIPRO
• 9.14 POLYMED
• 9.15 TERUMO